Biomaterials for intranasal and inhaled vaccine delivery.
Nat Rev Bioeng
; 1(2): 83-84, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-36987501
ABSTRACT
Delivery of vaccines by nasal sprays may enable more robust, protective mucosal immune responses against infectious diseases, such as COVID-19, compared with intramuscular injection. In this Comment, we highlight how biomaterials can be designed to allow intranasal and inhaled vaccination.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Nat Rev Bioeng
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos